Compare Globalstar (GSAT) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globalstar vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Globalstar trades at $83.8 (market cap $10.78B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Globalstar is more actively traded (723,953 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 21 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GSAT | HALO | |
|---|---|---|
Market Cap | $10.78B | $12.58B |
Volume | 723,953 | 2,179,278 |
Sector | Media | Health |
52-Week High | $84.43 | $115.22 |
52-Week Low | $41.54 | $61.63 |
Typical Hold Time | 21 Days | 1 Days |
Enterprise Value | $10.79B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Globalstar
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
